<DOC>
	<DOCNO>NCT01895088</DOCNO>
	<brief_summary>This 2 year follow study monitor long term safety ACI 7000PDT subject still implant ACI successfully complete ACU-P08-020/020A study .</brief_summary>
	<brief_title>A Continuation Study To Monitor The Long Term Safety Of Patients Completing Protocols ACU-P08-020/020A</brief_title>
	<detailed_description>This two year follow study design monitor obtain long-term safety data ACI 7000PDT subject participate successfully complete ACU-P08-020/020A study . Subjects must able provide voluntary informed consent , must sign give copy write Informed Consent form prior participate . This continuation study follow subject still implant ACI include two visit , 12-month interval , subject exit ( Month 36 ) ACU-P08-020/020A study . The first visit Month 48 follow implantation follow final Month 60 visit . The study parameter measure two visit include : - Specular microscopy - Slit lamp fundus examination ( ocular health ) - Corrected uncorrected visual acuity - Manifest mid-point refraction - Corneal topography - Dry eye assessment - Mesopic Photopic contrast sensitivity - Adverse event complication All site participate ACU-P08-020/020A study invite participate continuation study .</detailed_description>
	<mesh_term>Presbyopia</mesh_term>
	<criteria>Patients must complete participation ACUP08020/020A clinical trial . Patients must able provide voluntary informed consent , must sign give copy write Informed Consent form . Patients complete ACUP08020/020A .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>presbyopia</keyword>
</DOC>